Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Ortqvist (Stockholm, Sweden). Vaccination and other preventive measures for CAP and HAP. Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections

Member's Comments

No comment yet.

Related content which might interest you: Vaccination and other preventive measures for community acquired pneumonia Source: Annual Congress 2004 - PG22 - New perspectives in pneumonia treatment and prophylaxis Year: 2004 Choice and adherence in preventive treatment for tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 523s Year: 2003 Outcome of influenza vaccination in elderly with pneumonia Source: International Congress 2019 – Airway infection in COPD Year: 2019 Preventive measures for respiratory infections and tuberculosis Source: ERS Course 2018 - Respiratory Infections Year: 2018 Impact of influenza vaccination in patients with CAP Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009 Assessment of BCG immunization effectiveness in children from TB infection sources Source: Annual Congress 2010 - Tuberculosis in children Year: 2010 Impact of guidelines on HAP and VAP outcomes Source: Eur Respir Mon 2011; 53: 66-73 Year: 2011 Efficacy of vaccination to prevent pneumococcal infection in organized communities Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 Effects of vaccination on clinical presentation of community acquired pneumonia (CAP) Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Impact of introducing the 10-valent pneumococcal conjugate vaccine on childhood hospitalizations for bacterial pneumonia in Brazil Source: Annual Congress 2013 –Paediatric respiratory epidemiology: bronchiolitis and asthma Year: 2013 Clinical and epidemiological assessment of the regional program of vaccination for pneumococcal infections Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects Source: Eur Respir J 2005; 26: 1086-1091 Year: 2005 Pneumococcal and influenza vaccine uptake in patients discharged from an acute medical hospital Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013 Influence of vaccine prevention of pneumoccocus conjugated vaccine on mortality in patients with COPD Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Pneumococcal vaccine: clinical factors as facilitators or barriers to vaccination Source: Eur Respir J 2005; 26: Suppl. 49, 545s Year: 2005 Effectiveness of the pneumococcal polysaccharide vaccine in preventing pneumonia in the elderly Source: Eur Respir J 2010; 36: 608-614 Year: 2010 Beliefs and attitudes of health care workers on influenza and pneumococcal vaccine Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care Year: 2012 Pneumococcal vaccination practices and recommendations around the world Source: International Congress 2017 – Global challenges in respiratory medicine Year: 2017 Simultaneous use of probiotics and vaccines for prevention of pneumonia and respiratory infections in servicemen Source: Eur Respir J 2006; 28: Suppl. 50, 154s Year: 2006